Advances in biotechnology, a greater understanding of the immunopathogenesis of rheumatoid arthritis (RA) and a desire for more effective therapeutics have led to the development of a class of ...
People receiving a year of abatacept (Orencia) injections had onset of rheumatoid arthritis postponed by up to four years, researchers reported Jan. 20 in The Lancet Rheumatology. Currently, no ...
Original Medicare covers most medically necessary treatments for rheumatoid arthritis (RA), including biologics like adalimumab (Humira), etanercept (Enbrel), infliximab (Remicade, Inflectra), and ...
Patients who require biologic disease-modifying antirheumatic drugs (DMARDs) for severe RA are less likely to achieve sustained DMARD-free remission than those not needing the medication. Patients ...
Asian patients are half as likely to be started on biologic drugs for rheumatoid arthritis as white patients, new research has shown. The researchers also found that patients over 65 were 60% less ...
An implantable vagus nerve stimulation device yielded an ACR20 response rate of more than 52% at 12 months in patients with rheumatoid arthritis, according to findings published in Nature ...
Rheumatoid arthritis is a painful, progressive joint disease characterized by particularly acute flare-ups. Biologics, used to treat autoimmune diseases such as rheumatoid arthritis, target symptom ...
Treating people who are at high risk of rheumatoid arthritis (RA) can delay the onset of the disease for several years, with ...
Treatment with biologics does not increase the risk of a second malignancy in rheumatoid arthritis patients who have a history of cancer, according to new research findings presented this week at the ...
NEW YORK (Reuters Health) - Treating rheumatoid arthritis with "biologic" immunosuppressive drugs, such as TNF-blockers, neither increases nor decreases the risk of heart attack or stroke compared ...
The class of anti-inflammatory drugs known as TNF-inhibitors has brought relief to many sufferers of rheumatoid arthritis, ...